Coronary artery disease

Transforming complex PCI procedures into confident cardiac care 

 
Philips coronary artery disease (CAD) solutions consist of advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services, work together to efficiently support every step of coronary procedures. From diagnosis to restoring vessel patency, the coronary suite ecosystem is designed to enhance performance and efficiency today while serving as your launching pad to the future and keeping you close to the heart of CAD.

Interventional cathlab 

Improving cath lab performance while staying close to the heart

In the complex cath lab landscape you need to know your path in advance. Philips offers a fully integrated ecosystem designed to meet today’s challenges and provide you with more information faster. This enhances cath lab performance, supporting confident decisions and exceptional patient care. Our CAD solutions work together to help you provide quick, confident diagnosis, along with effective, efficient treatment – ultimately contributing to improved outcomes.

Azurion performing PCI procedure on a patient

Azurion

Reduce 17% of procedure time1 by experiencing the outstanding performance of the Azurion 7 M12. This industry-leading image-guided solution supports better patient care and operational efficiency with seamless control from a single tableside touch screen for fast, informed decisions in the sterile field.

Dynamic Coronary Roadmap

Dynamic Coronary Roadmap

Find the right path and improve PCI outcomes. This Philips exclusive solution offers motion-compensated, real-time navigational guidance of coronary arteries and reduces contrast agent by 28.8%² 

Intra sight

IntraSight

The IntraSight applications platform is where imaging, physiology, co-registration3 and software all come together to clearly identify coronary and peripheral artery disease, and allow you to plan the correct course of action for more optimized treatment plans. 

Technologies and innovations

  • iFR Clinical data & Patient Study

    Backed by clinically validated patient data in the largest physiology studies ever, learn how iFR reduces costs, procedural time and patient discomfort.

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

Footnotes
 

[1] Co-registration tools available within IntraSight 7 configuration via SyncVision.

[2] Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.

[3] Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR-SWEDEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med. 2017;376:1813-1823.

[4] Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017;376: 1824-1834.

Always read the label and follow the directions for use.

Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.

Products subject to country availability. Please contact your local sales representative.

©2024 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.